These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
415 related items for PubMed ID: 16196367
21. In vitro activity of beta-lactam and non-beta-lactam antibiotics in extended-spectrum beta-lactamase-producing clinical isolates of Escherichia coli. Puerto AS, Fernández JG, del Castillo Jde D, Pino MJ, Angulo GP. Diagn Microbiol Infect Dis; 2006 Feb; 54(2):135-9. PubMed ID: 16406187 [Abstract] [Full Text] [Related]
22. [Characterization of the resistance to combinations of beta lactams and inhibitors of beta-lactamases in Escherichia coli. Effect of the type and amount of beta-lactamase production]. del Mar Pérez-Moreno M, Pous-Miralles G, Romera-Sastre G, Panisello-Bertomeu JM, Jardí-Baiges AM, Zarazoga-López J. Enferm Infecc Microbiol Clin; 1997 Nov; 15(9):477-81. PubMed ID: 9527373 [Abstract] [Full Text] [Related]
23. First report of the emergence of CTX-M-type extended-spectrum beta-lactamases (ESBLs) as the predominant ESBL isolated in a U.S. health care system. Lewis JS, Herrera M, Wickes B, Patterson JE, Jorgensen JH. Antimicrob Agents Chemother; 2007 Nov; 51(11):4015-21. PubMed ID: 17724160 [Abstract] [Full Text] [Related]
24. Mechanisms of resistance to expanded-spectrum cephalosporins in Escherichia coli isolates recovered in a Spanish hospital. Briñas L, Lantero M, de Diego I, Alvarez M, Zarazaga M, Torres C. J Antimicrob Chemother; 2005 Dec; 56(6):1107-10. PubMed ID: 16239288 [Abstract] [Full Text] [Related]
25. Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli. Rodríguez-Baño J, Alcalá JC, Cisneros JM, Grill F, Oliver A, Horcajada JP, Tórtola T, Mirelis B, Navarro G, Cuenca M, Esteve M, Peña C, Llanos AC, Cantón R, Pascual A. Arch Intern Med; 2008 Sep 22; 168(17):1897-902. PubMed ID: 18809817 [Abstract] [Full Text] [Related]
26. Overcoming resistance to beta-lactamase inhibitors: comparing sulbactam to novel inhibitors against clavulanate resistant SHV enzymes with substitutions at Ambler position 244. Thomson JM, Distler AM, Bonomo RA. Biochemistry; 2007 Oct 09; 46(40):11361-8. PubMed ID: 17848099 [Abstract] [Full Text] [Related]
27. Prevalence and significance of a negative extended-spectrum beta-lactamase (ESBL) confirmation test result after a positive ESBL screening test result for isolates of Escherichia coli and Klebsiella pneumoniae: results from the SENTRY Asia-Pacific Surveillance Program. Bell JM, Chitsaz M, Turnidge JD, Barton M, Walters LJ, Jones RN. J Clin Microbiol; 2007 May 09; 45(5):1478-82. PubMed ID: 17344367 [Abstract] [Full Text] [Related]
31. In vitro susceptibilities of Escherichia coli and Klebsiella spp. to ampicillin-sulbactam and amoxicillin-clavulanic acid. Kacmaz B, Sultan N. Jpn J Infect Dis; 2007 Jul 09; 60(4):227-9. PubMed ID: 17642541 [Abstract] [Full Text] [Related]
32. Prevalence of beta-lactams resistance among Escherichia coli clinical isolates from a hospital in Algiers. Messai Y, Benhassine T, Naim M, Paul G, Bakour R. Rev Esp Quimioter; 2006 Jun 09; 19(2):144-51. PubMed ID: 16964332 [Abstract] [Full Text] [Related]
33. Bactericidal activity of oral beta-lactam antibiotics in plasma and urine versus isogenic Escherichia coli strains producing broad- and extended-spectrum beta-lactamases. Bedenic B, Vranes J, Suto S, Zagar Z. Int J Antimicrob Agents; 2005 Jun 09; 25(6):479-87. PubMed ID: 15894465 [Abstract] [Full Text] [Related]
34. Variety of beta-lactamases produced by amoxicillin-clavulanate-resistant Escherichia coli isolated in the northeastern United States. Kaye KS, Gold HS, Schwaber MJ, Venkataraman L, Qi Y, De Girolami PC, Samore MH, Anderson G, Rasheed JK, Tenover FC. Antimicrob Agents Chemother; 2004 May 09; 48(5):1520-5. PubMed ID: 15105100 [Abstract] [Full Text] [Related]
35. Characterization of beta-lactamases from urinary isolates of Escherichia coli in Tehran. Hosseini-Mazinani SM, Eftekhar F, Milani M, Ghandili S. Iran Biomed J; 2007 Apr 09; 11(2):95-99. PubMed ID: 18051951 [Abstract] [Full Text] [Related]
36. β-lactamases produced by amoxicillin-clavulanate-resistant enterobacteria isolated in Buenos Aires, Argentina: a new blaTEM gene. Di Conza JA, Badaracco A, Ayala J, Rodríguez C, Famiglietti A, Gutkind GO. Rev Argent Microbiol; 2014 Apr 09; 46(3):210-7. PubMed ID: 25444130 [Abstract] [Full Text] [Related]
37. Resistance pattern of extended-spectrum beta-lactamase producing Enterobacteriaceae isolates. Tuchiluş C, Poiată A, Bosnea D, Bădicuţ I, Buiuc D. Roum Arch Microbiol Immunol; 2002 Apr 09; 61(4):285-91. PubMed ID: 15055262 [Abstract] [Full Text] [Related]
38. Influence of the beta-lactam resistance phenotype on the cefuroxime versus cefditoren susceptibility of Streptococcus pneumoniae and Haemophilus influenzae recovered from children with acute otitis media. Fenoll A, Aguilar L, Robledo O, Giménez MJ, Tarragó D, Granizo JJ, Gimeno M, Coronel P. J Antimicrob Chemother; 2007 Aug 09; 60(2):323-7. PubMed ID: 17562681 [Abstract] [Full Text] [Related]
39. [Investigation of the frequency of extended spectrum beta-lactamases and antibiotic resistance in clinical isolates of Escherichia coli and Klebsiella sp]. Ekşi F, Ozer G, Balci I. Mikrobiyol Bul; 2007 Jul 09; 41(3):447-52. PubMed ID: 17933257 [Abstract] [Full Text] [Related]
40. β-Lactamases in amoxicillin-clavulanate-resistant Escherichia coli strains isolated from a Chinese tertiary hospital. Ding J, Ma X, Chen Z, Feng K. Diagn Microbiol Infect Dis; 2013 Aug 09; 76(4):532-3. PubMed ID: 23726651 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]